S-CAT6
S-CAT6 is an orally active anticancer agent. S-CAT6 reduces Gli1 protein levels and downregulates MGMT expression, thereby attenuating DNA repair and inhibiting the Hedgehog/Gli1 signaling pathway. S-CAT6 induces apoptosis and DNA double-strand breaks while inhibiting colony formation, migration, and invasion. S-CAT6 in combination with Temozolomide (HY-17364) inhibits tumor growth in glioblastoma xenograft mouse models. S-CAT6 can be used for research on glioblastoma.
For research use only. We do not sell to patients.
- Formula: C28H33NO4
- Molecular Weight:447.57
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
Gli1 |
MGMT |
Hedgehog |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| U-87MG ATCC | IC50 |
14.08 nM
|
Antiproliferative activity against human GBM U87MG cells assessed as viability reduction incubated 72 hrs by MTT assay.
Antiproliferative activity against human GBM U87MG cells assessed as viability reduction incubated 72 hrs by MTT assay.
|
42874267 |
| U-251 | IC50 |
3.32 nM
|
Antiproliferative activity against human GBM U251/TMZ cells assessed as viability reduction incubated 72 hrs by MTT assay.
Antiproliferative activity against human GBM U251/TMZ cells assessed as viability reduction incubated 72 hrs by MTT assay.
|
42874267 |
| T98G | IC50 |
11.45 nM
|
Antiproliferative activity against human GBM T98G cells assessed as viability reduction incubated 72 hrs by MTT assay.
Antiproliferative activity against human GBM T98G cells assessed as viability reduction incubated 72 hrs by MTT assay.
|
42874267 |
| GES1 | CC50 |
358.55 nM
|
Cytotoxicity against human gastric mucosal epithelial GES-1 cells assessed as viability reduction incubated 72 hrs by MTT assay.
Cytotoxicity against human gastric mucosal epithelial GES-1 cells assessed as viability reduction incubated 72 hrs by MTT assay.
|
42874267 |
In Vitro
S-CAT6 (1-100 nM; 12 days) inhibits long-term clonogenic survival of T98G GBM cells[1].
S-CAT6 (1-100 nM; 24 h) inhibits T98G migration in the scratch wound healing assay[1].
S-CAT6 (1-100 nM; 24 h) inhibits the invasion of T98G through the Transwell membrane[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:T98G human GBM cells
-
Concentration:1, 10, and 100 nM
-
Incubation Time:12 days
-
Result:Colony formation was inhibited in a concentration-dependent manner.
Colony formation was reduced at 10 and 100 nM, with the strongest reduction at 100 nM.
-
Cell Line:T98G human GBM cells
-
Concentration:1, 10, and 100 nM
-
Incubation Time:24 h
-
Result:T98G wound-healing migration was reduced.
Significant reduction was observed at 10 and 100 nM compared with control.
-
Cell Line:T98G human GBM cells
-
Concentration:1, 10, and 100 nM
-
Incubation Time:24 h
-
Result:T98G invasion was significantly inhibited at 1, 10, and 100 nM.
Invaded cell numbers decreased with increasing concentration.
-
Cell Line:T98G human GBM cells
-
Concentration:1, 10, and 100 nM
-
Incubation Time:12 h
-
Result:A dose-dependent increase in Cy3-labeled TUNEL fluorescence occurred, indicating DNA fragmentation.
The apoptotic signal was evident at 10 nM and further increased at 100 nM.
-
Cell Line:T98G human GBM cells
-
Concentration:10, 100, and 1000 nM
-
Incubation Time:24 h
-
Result:Gli1 (160 kDa) and MGMT (21 kDa) were dose-dependently decreased.
Cleaved caspase-3 (17 kDa), cleaved PARP (89 kDa), and γ-H2AX (15 kDa) were increased.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NCG (female, 18-20 g)[1]
-
Dosage:15 mg/kg; 30 mg/kg
-
Administration:p.o. (intragastric), once daily for 13 days
-
Result:Single-agent administration produced tumor growth inhibition relative to vehicle of 15.2% at 15 mg/kg and 47.7% at 30 mg/kg.
The TMZ combination produced tumor growth inhibition of 92.2% relative to vehicle and 87.8% relative to TMZ alone.
All mice in the 15 mg/kg and 30 mg/kg single-agent and TMZ combination groups survived throughout the dosing period.
- RNA extraction experimental
- Annexin V plus membrane-impermeant dye apoptosis staining
- Cell migration
- Patient-Derived Orthotopic Xenograft (PDOX)
- Colony Formation (Clonogenic) Assay
- Detection of Apoptosis
- TUNEL staining for apoptotic DNA fragmentation
- Patient-Derived Xenograft (PDX)
- Apoptosis Solutions
- Brain Orthotopic Xenograft
- Cell invasion
- Splenic/Portal-Vein Liver Metastasis Xenograft
- Soft Agar Colony Formation Assay
- Subcutaneous Cell-Line-Derived Xenograft
- Orthotopic Cell-Line Xenograft
- Intraperitoneal/Peritoneal Dissemination Xenograft
Chemical Information
-
Molecular Weight 447.57
-
Formula C28H33NO4
-
SMILES
[H][C@@]12CCCCN1CC3=C(C4=C(C5=C3C=C(C(OC)=C5)OC)C=C(C=C4)OC(C(C)(C)C)=O)C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)